4 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow ABVD regimen: new trials by email Literature Review of ABVD regimen trials Research Report on ABVD regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma bleomycin sulfate, filgrastim, ABVD regimen - Lymphoma, Nonneoplastic Condition | Phase 2 | Completed | SWOG Cancer Research Network | 371 | 2009-07-01 | 2022-08-18 |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma bleomycin sulfate, ABVD regimen, carmustine - Lymphoma | Phase 3 | Terminated | French Innovative Leukemia Organisation | 442 | 2008-05-01 | 2016-09-16 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 552 | 2002-08-01 | 2025-08-05 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, Stanford V regimen - Lymphoma | Phase 3 | Unknown | Mount Vernon Cancer Centre at Mount Vernon Hospital | 850 | 2001-10-01 | 2013-09-20 |
| Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease bleomycin sulfate, filgrastim, ABVD regimen - Lymphoma | Phase 2 | Completed | Children's Oncology Group | 99 | 1999-10-01 | 2014-02-26 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, BEACOPP regimen - Lymphoma | Phase 3 | Active not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 1649 | 1998-10-01 | 2025-08-05 |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease bleomycin sulfate, ABVD regimen, chlorambucil - Lymphoma | Phase 3 | Completed | Medical Research Council | 800 | 1998-06-01 | 2013-12-04 |
Hodgkin Disease (7) · Lymphoma (7) · HIV Infections (1)
European Organisation for Research and Treatment of Cancer - EORTC (2) · Children's Oncology Group (1) · French Innovative Leukemia Organisation (1) · Medical Research Council (1) · Mount Vernon Cancer Centre at Mount Vernon Hospital (1) · SWOG Cancer Research Network (1)
France (3) · United Kingdom (3) · Australia (2) · Belgium (2) · Canada (2) · Netherlands (2) · Poland (2) · Spain (2) · United States (2) · Croatia (1) · Czechia (1) · Hungary (1) · Italy (1) · New Zealand (1) · Portugal (1)
Anna Sureda (1) · Barry W. Hancock, MD (1) · Bengt Glimelius, MD (1) · Christian Gisselbrecht, MD (1) · Christophe Ferme (1) · David C. Linch (1) · David Ma, MD (1) · Delphine Senecal (1) · Devinder Gill, MD (1) · E.M. Noordijk, MD (1) · H. Eghbali, MD (1) · Jose Thomas, MD (1) · Kara Kelly, MD (1) · Marine Divine, MD (1) · Oliver W. Press, MD, PhD (1)
PMID 16314615, PMID 21079154, PMID 27114593, PMID 28601705, PMID 29229324, PMID 30723079, PMID 31331918, PMID 40135712, PMID 42848781
2004 (1), U10CA032102 (1)